Volume 25, Issue 113, July 2021

Cutaneous mucormycosis with maxillary sinus fistula as a presenting feature of COVID-19: A rare case report

Mansi Patel¹, Dhruv Talwar^1♦, Sunil Kumar², Sourya Acharya³, Ayush Dubey¹, Vidyashree Hulkoti¹, Sameera Dronamraju¹

¹Post Graduate Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences and Research (Deemed to be university), Wardha, Maharashtra, India
²Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences and Research (Deemed to be university), Wardha, Maharashtra, India
³Professor and HOD, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences and Research (Deemed to be university), Wardha, Maharashtra, India

^♦Corresponding author
Post Graduate Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences and Research (Deemed to be university), Wardha, Maharashtra, India

ABSTRACT

Deadly secondary infections caused by Rhizopus species leading to mucormycosis have taken the world by storm. Most common presenting features of COVID-19 remain congectival congestion, headache and blurring of vision. However mucormycosis with a fistula manifesting as the primary symptom of COVID-19 is rare and this is the first case report of its kind to best of our knowledge. We report a case of 61 year old female who presented with a pus draining fistula on right side of her face. A Nasopharyngeal swab came positive for COVID-19 by Reverse Transcriptase polymerase chain reaction method. MRI para nasal sinus was suggestive of fungal sinusitis. Debriedment was done for the same and a swab was sent which showed growth of Rhizopus species on culture.

Keywords: COVID-19, Mucormycosis, Maxillary sinus fistula

Medical Science, 2021, 25(113), 1507-1512

PDF